Research Site

Winter Haven, Florida 33881

2 studies enrolling now · 19 studies all time

What they study most

Acute Coronary Syndrome, Arthritis, Rheumatoid; Arthritis, Psoriatic, Breast Cancer, Early Breast Cancer, Chronic Kidney Disease, Chronic Kidney Disease and Hypertension, Coronary Atherosclerosis, Cost Sharing, Acute Coronary Syndrome, Hypertension, Knee Osteoarthritis, Migraine Disorder, Migraine Disorders, Osteoarthritis, Knee

Studies at this site

• A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy — Recruiting now
• A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis — Recruiting now
• Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS — Recruiting now
• A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure. — Running, not enrolling
• A Long-Term Safety and Efficacy Study of Lorecivivint in Subjects With Osteoarthritis of the Knee — Stopped early
• Patient-Reported and Radiographic Outcomes in Evaluating Lorecivivint (SM04690) for the Treatment of Knee Osteoarthritis — Completed
• Patient-Reported Outcomes in Evaluating Lorecivivint (SM04690) for Moderate to Severe Knee Osteoarthritis (STRIDES-1) — Completed
• A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease — Stopped early
• Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124 — Completed
• Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC — Completed
• Evaluation of ALD403 (Eptinezumab) in the Prevention of Chronic Migraine — Completed
• A Multicenter Assessment of ALD403 in Frequent Episodic Migraine — Completed
• An Open Label Trial of ALD403 (Eptinezumab) in Chronic Migraine — Completed
• Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study — Completed
• Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis — Completed
• JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab — Completed
• An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes — Completed
• Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications — Completed
• CRESTOR Athero Imaging Head to Head IVUS Study — Completed